CVR 29148805Private limited company (ApS)Ikke-finansielle holdingselskaber (642020)København KFounded 25 Oct 2005
CVR registers no owner holding 5% or more.
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about NORDIC BIOTECH GENERAL PARTNER II ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexGross profit
-5.4K
DKK, annual report 2013
Result
-5.4K
DKK, annual report 2013
Equity
118.6K
DKK, annual report 2013
CVR registers no owner holding 5% or more.
Claus Tycho Bræstrupuntil 22 Nov 2013
Florian Schønhartinguntil 22 Nov 2013
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
Founded 25 Oct 2005.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2013, DKK: Result for the year -5.4K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2013, DKK: Total assets 136.1K, Equity 118.6K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|
| Gross profit | Not reported | Not reported | Not reported | Not reported | -5 |
| Operating profit | Not reported | Not reported | Not reported | -4 | Not reported |
| Result for the year | Not reported | Not reported | Not reported | -5 | -5 |
| Equity | Not reported | Not reported | Not reported | 124 | 119 |
| Total assets | Not reported | Not reported | Not reported | 140 | 136 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for NORDIC BIOTECH GENERAL PARTNER II ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 18 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 18 Nov 2026.
7 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
CVR-nummer:
29148805.
NAVN:
NORDIC BIOTECH GENERAL PARTNER II ApS I LIKVIDATION.
Adresse: c/o NB Capital ApS, Østergade 24A, 1. tv., 1100 København K.
Kommune: København.
Likvidation sluttet, og selskabet opløst
Likvidatorer:
Fratrådte:
Jakob Mosegaard Larsen, den 28.05.2015.
Revision:
Fratrådte:
null, den 28.05.2015.
Likvidation vedtaget 22.11.2013.
Tiltrådt som likvidator:
Advokat Jakob Mosegaard Larsen, 1459 København K, den 22.11.2013.
Ledelsen fratrådt.
Selskabet tegnes af likvidator.
Selskabets kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Direktion:
Udtrådt af direktionen:
Christian Karsten Hansen, den 31.05.2012.
Indtrådt i direktionen:
Claus Tycho Bræstrup, den 31.05.2012.
Revision:
Udtrådt af revisionen:
ERNST & YOUNG P/S, den 03.05.2011.
Indtrådt i revisionen:
CVR-NR. 26052394 ERNST & YOUNG P/S, Gyngemose Parkvej 50, 2860 Søborg, den 03.05.2011.
Ny adresse:
c/o NB Capital ApS, Østergade 24A, 1. tv., 1100 København K.
Vedtægter ændret:
23.08.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Christian Karsten Hansen, den 23.08.2010, Florian Schønharting, den 23.08.2010.
Direktion:
Indtrådt i direktionen:
Direktør Christian Karsten Hansen, den 23.08.2010, Direktør Florian Schønharting, den 23.08.2010.
Selskabet tegnes af den samlede direktion.
Stiftelsesdato:
25.10.2005.
Seneste vedtægtsdato:
25.10.2005.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 103,00.
Stiftere:
CVR-NR. 25146670 TECH GROWTH INVEST ApS, Østergade 5, 3., 1100 København K, den 25.10.2005, CVR-NR. 26213118 C. HANSEN INVEST ApS, Rungsted Strandvej 19, 2950 Vedbæk, den 25.10.2005.
Bestyrelse:
Direktør Christian Karsten Hansen, den 25.10.2005, Direktør Florian Schønharting, den 25.10.2005.
Selskabet tegnes af den samlede bestyrelse.
Revision:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Tagensvej 86, 2200 København N, den 25.10.2005.
Første regnskabsår:
25.10.2005 - 31.12.2006.
Regnskabsår:
01.01 - 31.12.
P-number 1011780667Østergade 24, 1100 København K